Drawing for INDIVISE

USPTO serial 79364254

INDIVISE

Reviewed by CopyMark Law Group

Status 401
Filing date
Status date
Registration date
—
Examiner
SMITH, BRIDGETT G
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INDIVISE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software and downloadable mobile applications for physicians and healthcare practitioners to support clinical decision and to receive personalized therapeutic recommendations; downloadable computer software and downloadable mobile applications as a medical device; downloadable computer software and downloadable mobile applications as a digital therapeuticSECTION 70 - CANCELLED—
042Design and development of software for use with medical technology; design and development of software for the collection and analysis of healthcare dataSECTION 70 - CANCELLED—
044Therapeutic services; providing medical information; medical advisory servicesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2023DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 26, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 5, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 4, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2023DOCKASSIGNED TO EXAMINER—
Mar 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 2, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance